Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis.

Katz LH, Fraser A, Gafter-Gvili A, Leibovici L, Tur-Kaspa R.

J Viral Hepat. 2008 Feb;15(2):89-102. doi: 10.1111/j.1365-2893.2007.00902.x. Review.

PMID:
18184191
2.

The difficulties of managing severe hepatitis B virus reactivation.

Roche B, Samuel D.

Liver Int. 2011 Jan;31 Suppl 1:104-10. doi: 10.1111/j.1478-3231.2010.02396.x. Review.

PMID:
21205146
3.
4.

Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.

Kohrt HE, Ouyang DL, Keeffe EB.

Aliment Pharmacol Ther. 2006 Oct 1;24(7):1003-16. Review.

5.

Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy.

Loomba R, Rowley A, Wesley R, Liang TJ, Hoofnagle JH, Pucino F, Csako G.

Ann Intern Med. 2008 Apr 1;148(7):519-28. Review. Erratum in: Ann Intern Med. 2009 May 5;150(9):657-8.

6.

Prophylactic lamivudine to improve the outcome of HBsAg-positive lymphoma patients during chemotherapy: a systematic review and meta-analysis.

Li H, Zhang HM, Chen LF, Chen YQ, Chen L, Ren H, Hu HD.

Clin Res Hepatol Gastroenterol. 2015 Feb;39(1):80-92. doi: 10.1016/j.clinre.2014.07.010. Epub 2014 Sep 4. Review.

PMID:
25199680
7.

Hepatitis B core-related antigen assay is useful for monitoring the antiviral effects of nucleoside analogue therapy.

Tanaka E, Matsumoto A, Yoshizawa K, Maki N.

Intervirology. 2008;51 Suppl 1:3-6. doi: 10.1159/000122592. Epub 2008 Jun 10. Review.

PMID:
18544941
8.

Ribavirin monotherapy for chronic hepatitis C infection: a Cochrane Hepato-Biliary Group systematic review and meta-analysis of randomized trials.

Brok J, Gluud LL, Gluud C.

Am J Gastroenterol. 2006 Apr;101(4):842-7. Epub 2006 Feb 22. Review.

PMID:
16494584
9.
11.

Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies.

Lalazar G, Rund D, Shouval D.

Br J Haematol. 2007 Mar;136(5):699-712. Review. Erratum in: Br J Haematol. 2007 Apr;137(1):81.

PMID:
17338776
12.

[Prevention and therapy of reactivation of hepatitis B in immunosuppressed patients].

von Wagner M, Zeuzem S.

Dtsch Med Wochenschr. 2009 Feb;134(6):255-8. doi: 10.1055/s-0028-1123989. Epub 2009 Jan 29. Review. German.

PMID:
19180418
13.

Meta-analysis: anti-viral therapy of hepatitis B virus-associated glomerulonephritis.

Fabrizi F, Dixit V, Martin P.

Aliment Pharmacol Ther. 2006 Sep 1;24(5):781-8. Review.

14.

Use of tumor necrosis factor-alpha-blocking agents in hepatitis B virus-positive patients: reports of 3 cases and review of the literature.

Zingarelli S, Frassi M, Bazzani C, Scarsi M, Puoti M, AirĂ² P.

J Rheumatol. 2009 Jun;36(6):1188-94. doi: 10.3899/jrheum.081246. Epub 2009 May 15. Review.

PMID:
19447932
15.
16.

Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis.

Shi Z, Yang Y, Ma L, Li X, Schreiber A.

Obstet Gynecol. 2010 Jul;116(1):147-59. doi: 10.1097/AOG.0b013e3181e45951. Review. Erratum in: Obstet Gynecol. 2013 Feb;121(2 Pt 1):384.

PMID:
20567182
17.
18.

Estimating the future health burden of chronic hepatitis B and the impact of therapy in Spain.

Idris BI, Brosa M, Richardus JH, Esteban R, Schalm SW, Buti M.

Eur J Gastroenterol Hepatol. 2008 Apr;20(4):320-6. doi: 10.1097/MEG.0b013e3282f340c8. Review.

PMID:
18334876
19.

Antiviral prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.

Kohrt HE, Ouyang DL, Keeffe EB.

Clin Liver Dis. 2007 Nov;11(4):965-91, x. Review.

PMID:
17981237
20.

Lamivudine versus telbivudine in the treatment of chronic hepatitis B: a systematic review and meta-analysis.

Jiang H, Wang J, Zhao W.

Eur J Clin Microbiol Infect Dis. 2013 Jan;32(1):11-8. doi: 10.1007/s10096-012-1723-6. Epub 2012 Aug 17. Review.

PMID:
22898727

Supplemental Content

Support Center